Biopharma
🇺🇸 FDA Page 4FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Global biopharma insights for investors & BD. Track drug development, M&A, and market trends shaping the pharmaceutical landscape.
Showing 37–48 of 69 articles
Asia Surges as Biopharma Innovation Hub, Driving Global Drug Approvals
Merck's ADC Success: Insights from Global Trial Results
Niowave's $75M Radiopharmaceutical Plant: Industry Implications
Fierce Pharma Asia: Key Insights on Recent Deals and Trends
Pfizer and Innovent's $10B Cancer Drug Deal: Key Insights
Trump's Pharma Deals Under Scrutiny: Insights and Implications
Trump's Drug-Pricing Deals: New Product Launches on the Horizon
FDA Calendar 2026: Key Approval Dates and PDUFA Insights
CordenPharma Expands Production Capacity with New CDMO Deal
AstraZeneca's Breast Cancer Pill and ADAP Deal Insights
Eli Lilly's New Gene Therapy and Strategic Deals: Insights for Investors
SK bioscience's $260M Deal for Varicella Vaccine Production in Colombia